Survival outcomes after toxicity-related dose modification of 5-fluorouracil, leucovorin and oxalipatin (FOLFOX) in stage III, resected colorectal cancer patients

被引：0
|
作者：
Ha, F. J. [1 ]
Aksakal, G. [1 ]
Chong, G. [1 ]
机构：
[1] Austin Hosp, Dept Med Oncol, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
210P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] 5-Fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer
    Seitz, JF
    SEMINARS IN ONCOLOGY, 2001, 28 (01) : 41 - 44
  • [2] Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
    André, T
    Louvet, C
    Raymond, E
    Tournigand, C
    de Gramont, A
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1251 - 1253
  • [3] Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
    Jeong Eun Kim
    Yong Sang Hong
    Hwa Jung Kim
    Kyu-pyo Kim
    Sun Young Kim
    Seok-Byung Lim
    In Ja Park
    Chan Wook Kim
    Yong Sik Yoon
    Chang Sik Yu
    Jin Cheon Kim
    Ji Hun Kim
    Tae Won Kim
    Annals of Surgical Oncology, 2017, 24 : 1289 - 1294
  • [4] Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
    Kim, Jeong Eun
    Hong, Yong Sang
    Kim, Hwa Jung
    Kim, Kyu-pyo
    Kim, Sun Young
    Lim, Seok-Byung
    Park, In Ja
    Kim, Chan Wook
    Yoon, Yong Sik
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Ji Hun
    Kim, Tae Won
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (05) : 1289 - 1294
  • [5] UNEXPECTED FATAL TOXICITY RELATED TO LOW-DOSE LEUCOVORIN WITH 5-FLUOROURACIL TREATMENT IN METASTATIC COLORECTAL-CANCER
    ADENIS, A
    BONNETERRE, J
    PION, JM
    DEGARDIN, M
    HORNER, D
    ANNALS OF ONCOLOGY, 1993, 4 (02) : 174 - 175
  • [6] Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
    Sobrero, A
    Frassineti, G
    Falcone, A
    Dogliotti, L
    Rosso, R
    Costanzo, FD
    Bruzzi, P
    BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 24 - 29
  • [7] Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
    A Sobrero
    G Frassineti
    A Falcone
    L Dogliotti
    R Rosso
    F D Costanzo
    P Bruzzi
    British Journal of Cancer, 2005, 92 : 24 - 29
  • [8] Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?
    Soveri, L. M.
    Hermunen, K.
    de Gramont, A.
    Poussa, T.
    Quinaux, E.
    Bono, P.
    Andre, T.
    Osterlund, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (17) : 2966 - 2974
  • [9] Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer
    Saltz, Leonard
    Badarinath, Suprith
    Dakhil, Shaker
    Bienvenu, Bryan
    Harker, W. Graydon
    Birchfield, George
    Tokaz, Laurence K.
    Barrera, David
    Conkling, Paul R.
    O'Rourke, Mark A.
    Richards, Donald A.
    Reidy, Diane
    Solit, David
    Vakiani, Efsevia
    Capanu, Marinella
    Scales, Amy
    Zhan, Feng
    Boehm, Kristi A.
    Asmar, Lina
    Cohn, Allen
    CLINICAL COLORECTAL CANCER, 2012, 11 (02) : 101 - 111
  • [10] Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients
    Chen, Hong-Hwa
    Chen, William Tzu-Liang
    Lee, Hsin-Chung
    Lin, Jen-Kou
    Fang, Chuan-Yin
    Chou, Yenn-Hwei
    Lin, Peng-Chan
    Lin, Bo-Wen
    Huang, Chi-Chou
    Yeh, Chung-Hung
    Hsu, Hsi-Hsien
    Chen, Hung-Chang
    Ting, Wen-Chien
    Yang, Ming-Chin
    Tan, Elise Chia-Hui
    QUALITY OF LIFE RESEARCH, 2015, 24 (02) : 473 - 484
12345